Table of Contents
Overview
New York, NY – July 14, 2025: The Global Radiation Therapy Market is projected to grow from US$ 7.4 billion in 2023 to around US$ 13.4 billion by 2033. This reflects a CAGR of 6.1% during the forecast period from 2024 to 2033. Radiation therapy plays a vital role in cancer treatment and is used in nearly 50% of all cancer cases. It works by delivering high-energy radiation to kill cancer cells while protecting surrounding healthy tissues. As cancer rates continue to climb globally, the need for effective and accessible radiation treatment is becoming more urgent.
Developed nations are focusing on upgrading outdated equipment and expanding their cancer care infrastructure. Government investment in modern technologies, such as image-guided radiation therapy and proton therapy, is helping hospitals offer better treatment. These advanced systems reduce treatment time, limit side effects, and allow for more precise targeting of tumors. As a result, patient outcomes are improving and healthcare systems can serve more patients efficiently. This shift toward high-performance equipment is a key driver of market growth.
In contrast, many low- and middle-income countries struggle with limited access to radiation therapy. Barriers include a shortage of machines, trained professionals, and treatment centers. To address this gap, global organizations like the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA) are leading support initiatives. These programs aim to improve infrastructure, train healthcare workers, and ensure that treatment facilities follow international standards. Bridging this gap is essential to ensure equitable cancer care worldwide.
Healthcare policy is also shaping the market. In several countries, value-based care models and bundled payments are being introduced to promote the use of advanced radiation therapies. These payment systems reward hospitals for delivering effective, cost-efficient treatment. As a result, more providers are adopting the latest technologies, which further boosts market growth. Policies that support reimbursement for newer treatments are proving critical in encouraging innovation and adoption.
Lastly, training and safety remain top priorities. Organizations such as the IAEA run training sessions and provide technical support to ensure safe, high-quality care. These efforts help build trust in radiation therapy systems and promote long-term investment. As technology evolves and global cooperation expands, radiation therapy is becoming more accurate, accessible, and effective. This progress is essential in the global fight against cancer and continues to create strong momentum for the market.
Key Takeaways
- According to recent insights, the global radiation therapy market is set to rise from US$ 7.4 Billion in 2023 to US$ 13.4 Billion by 2033.
- Analysts noted a 6.1% compound annual growth rate (CAGR) for the radiation therapy market during the forecast period from 2024 to 2033.
- In 2023, External Beam Radiation Therapy emerged as the leading type, capturing over 49% of the total market share globally.
- Breast cancer remained the top application for radiation therapy in 2023, contributing more than 28% to the overall market.
- Experts observed that opioids led the drug class segment in 2023, securing over 28% of the total market revenue.
- North America topped the regional charts in 2023, commanding a dominant 44% market share, with a value of US$ 3.2 billion.
Segmentation Analysis
In 2023, External Beam Radiation Therapy led the Radiation Therapy Market’s Type Segment, capturing over 49% of the share. This includes techniques like Intensity-Modulated and Image-Guided Radiation Therapy. These methods help deliver targeted radiation, minimizing harm to surrounding healthy tissue. Proton therapy, a sub-type, uses proton beams to strike only the tumor with high precision. This approach is key in lowering side effects. Internal Radiation Therapy, or brachytherapy, places radioactive sources near tumors. It’s highly effective for prostate, breast, and cervical cancers due to its focused dose delivery.
Systemic Radiation Therapy uses radioactive substances that travel through the bloodstream. This allows radiation to directly reach cancer cells while limiting exposure to healthy tissues. It is especially useful in treating thyroid cancer. In 2023, Breast Cancer dominated the Application Segment, holding over a 28% market share. Radiation therapy plays a critical role in breast cancer treatment plans. Lung, prostate, and colorectal cancers also contribute significantly. Each cancer type uses radiation therapy in unique ways, tailored to its treatment needs and clinical goals.
Hospitals dominated the End-Use Segment in 2023 due to their advanced equipment and integrated care services. They offer full-spectrum cancer care, supporting diagnosis, treatment, and follow-up. Specialized radiotherapy centers also hold a strong position. These centers provide focused treatment using expert staff and the latest technologies. Ambulatory Surgery Centers (ASCs) are growing, offering outpatient services that reduce costs and time. Cancer research institutes contribute by developing new radiation techniques. They play a vital role in driving innovation and enhancing radiation therapy outcomes across all care settings.
Regional Analysis
In 2023, North America held a leading position in the radiation therapy market, with over 44% share, reaching US$ 3.2 billion in value. This growth is driven by advanced healthcare infrastructure and strong R&D investment. Innovative treatments like image-guided radiation therapy (IGRT) and proton therapy have improved accuracy, increasing adoption. High healthcare spending across the region supports access to cutting-edge care. The U.S. and Canada lead in research activities, boosting safety and effectiveness in radiation therapy, making the region a global leader in cancer treatment options.
Supportive government policies and strong private sector investments help expand North America’s radiation therapy market. These efforts enable faster adoption of new technologies and upgrade existing systems. The region’s high cancer rates create strong demand for reliable treatment options. Quick regulatory approvals help bring innovations to market faster. Awareness campaigns and early detection programs also play a role. They lead to earlier diagnoses and prompt treatment, increasing demand for radiation therapy and strengthening North America’s market dominance.
Key Players Analysis
Accuray Incorporated and Brainlab AG continue to shape the radiation‑therapy landscape. Accuray delivers precision‑driven systems, supported by a strong balance sheet that funds fast product updates and wider geographic reach. Its newest software releases sharpen dose delivery and patient safety. Brainlab, a leader in digital workflows, posts robust revenue gains as hospitals adopt its adaptive‑planning platforms. The firm layers artificial intelligence onto its tools to lift clinical accuracy. Both players pursue relentless innovation to defend share in a swiftly advancing oncology‑technology arena.
Curium, Canon Medical Systems, and Elekta AB widen the sector’s capabilities. Curium tops the radiopharmaceutical field, supplying critical tracers for diagnosis and targeted therapy, a position that ensures steady cash flow. Canon Medical leverages its imaging pedigree to deliver integrated radiation‑therapy equipment and deepens reach through collaborations. Elekta channels strong R&D into precise treatment platforms and drives adoption in emerging markets. Collectively, these companies broaden access to high‑quality cancer care and reinforce growth across the global radiation‑therapy market.
Emerging Trends
Shorter Treatment Schedules Are Becoming Common
Radiation therapy is shifting to hypofractionation, where the total dose is delivered in just a few sessions instead of daily visits over many weeks. Breast‑ and prostate‑cancer patients benefit most because they spend less time in hospitals and get back to normal life sooner. Fewer visits lower stress, ease travel burdens, and improve comfort. Hospitals win, too, by freeing up machines and staff for more patients, making overall cancer care faster and more accessible.
Artificial Intelligence (AI) Is Speeding Up the Process
Smart AI software now handles labor‑intensive steps such as contouring tumors and protecting healthy organs. Tasks that once took clinicians hours are finished in minutes, so treatment can start sooner. AI also spots tiny details humans might miss, reducing errors and boosting safety. With quicker, more precise plans, doctors gain extra time to focus on complex decisions, and patients receive high‑quality care without long waits.
Proton Therapy Is Becoming More Accessible
Proton therapy delivers radiation that stops precisely at the tumor, sparing nearby organs and tissues. Historically, only large academic centers could afford the massive equipment. Compact, lower‑cost systems are changing that, allowing more regional hospitals to add proton rooms. Children, and adults with tumors near critical structures like the brainstem or heart, see fewer side effects. As availability widens, a growing number of patients gain access to this ultra‑precise option.
Radiation and Medicine Combined: Theranostics
Theranostics fuses diagnostic imaging with targeted radiation therapy in a single drug. The compound homes in on specific cancer cells—such as those in prostate or neuroendocrine tumors—lighting them up for imaging and then delivering a therapeutic radioactive payload. Healthy tissue is largely spared. Doctors can monitor how well the treatment works in real time and adjust quickly if needed. This personalized, “seek‑and‑destroy” approach is drawing intense interest as a next‑generation oncology tool.
Use Cases
After Surgery to Stop Cancer From Coming Back
Radiation therapy is often used after surgery. It helps destroy any remaining cancer cells. This is common in breast and rectal cancer cases. Even when the main tumor is removed, small cancer cells may still be left behind. Radiation lowers the chance of the cancer returning. It targets the area where the tumor was located. This makes treatment more effective. Doctors use this method to improve long-term recovery. It also helps avoid future surgeries or stronger treatments. Radiation after surgery is usually safe and well tolerated. It plays an important role in many standard cancer treatment plans.
As the Main Treatment When Surgery Isn’t Possible
Some people cannot have surgery due to age or other health problems. In such cases, radiation therapy can be used as the main treatment. It helps shrink or destroy the tumor. This method is often used for lung, head, neck, or prostate cancer. Radiation works by damaging cancer cells so they can’t grow or spread. It is a non-invasive option. This means there are no cuts or wounds involved. People with weak immune systems or heart conditions often benefit from this. Radiation can still offer effective cancer control without surgery.
For Brain Tumors and When Cancer Spreads to the Brain
Radiation therapy is used to treat brain tumors and brain metastases. It targets the tumor directly, avoiding damage to healthy brain tissue. This helps preserve memory and other brain functions. Treatments like stereotactic radiosurgery deliver high doses in one or few sessions. They are often used for small or hard-to-reach brain tumors. Radiation is also useful when surgery is too risky. It can help reduce tumor size, ease symptoms, and slow growth. This therapy is often combined with other treatments. It gives patients better control over brain-related cancers.
For Children With Brain or Spine Tumors
Radiation therapy is sometimes used in children with cancer. It is often needed for brain and spine tumors. Children’s bodies are still developing, so doctors use special care. They choose precise techniques like proton therapy. Proton therapy reduces harm to healthy tissues. This helps avoid long-term side effects. Radiation is often combined with surgery or chemotherapy. The goal is to treat the tumor without affecting growth or learning. Each plan is customized to the child’s needs. Modern technology makes pediatric radiation therapy safer and more accurate than before.
Conclusion
Radiation therapy is a key part of modern cancer treatment and continues to grow in importance. New technologies like proton therapy and AI are making treatments faster, safer, and more precise. Hospitals are upgrading systems to meet rising patient needs, while global health groups work to close access gaps in lower-income regions. Supportive policies and growing investment in cancer care are pushing the market forward. At the same time, shorter treatment schedules and personalized approaches are improving the patient experience. As innovation spreads and training improves, radiation therapy is becoming more accessible worldwide. This ongoing progress makes it a vital tool in the global fight against cancer.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
